Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Hair loss in women may have causes other than hormones.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Sex steroids affect the MafB gene differently in male and female hamsters.

Dutasteride is more effective than finasteride for hair loss treatment.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

PCOS can cause unusual symptoms like late puberty and enlarged clitoris, making diagnosis difficult.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Testosterone significantly affects urination differences between male and female mice.